Speaking of cancer it is human silent killer. It will attack uncontrollably if its number (cell) multiplies rapidly. Once they form massively it gives negative effect on usual operation of the adjoining tissue. At this point of time there must be action on treating this problem. If this would not be treated well cancer cell would pass-through bloodstream reaching some body parts. This is what we call metastasis which is already very hard to control or to be cured. We all have cancer cells scattered all over our body parts and no one spared of that silent killer. Young and old people can have it especially if our body immune system got weakens that could lower our resistance. Cancer problem on young generation are far more different than on older generations. The same medical procedures in fighting for it but different form when you look at it under the microscope. The chances are, younger generation responded better than the older one in terms of treatment.
The production of cells in bone marrow consists of several steps. Cells get converted into many intermediate types before forming white, red cells and platelets.
The treatment of leukemia is focused towards achieving a complete remission with minimal side-effects. Complete remission refers to absence of leukemia traces at cellular level. Patients who present no evidence of malignant cellular activity after completing the treatment of leukemia are considered to be completely cured. By contrast, relapse indicates a recurrence of leukemia specific symptoms and physiological signs.
In the case of patients with acute leukemia, a remission that lasts for more than five years after the treatment suggests a complete recovery. This five-year period is considered to be critical for leukemia sufferers, as it can make the difference between relapse and complete recovery.
In the last few decades, the five-year survival period of patients with leukemia has tripled. While in the 60's the five-year survival rate was around 15 percent, nowadays it revolves around 50 percent. This five-year survival period is strongly influenced by patients' age and the type of leukemia. Statistics indicate that the five-year survival rate for patients with acute lymphocytic leukemia (ALL) is around 60 percent, while the five-year survival rate for patients with chronic lymphocytic leukemia (CLL) is higher, reaching the value of 70 percent. By contrast, the prognosis of patients with myelogenous leukemia is less favorable. The same five-year survival rate for patients diagnosed with acute myelogenous leukemia (AML) is around 14 percent, while an estimated 32 percent of patients with chronic myelogenous leukemia (CML) exceed this five-year survival period.
Acute refers to the fact that this cancer has potential to become fatal in quick time. Acute lymphocytic leukemia requires immediate treatment otherwise recovery becomes impossible. It is mostly seen in childhood. Acute myelogenous and chronic cancer does not require immediate treatment.
Patient suffering from chronic leukemia are kept under observation and treated only when leukemia starts to damage body tissues. Chronic type is mostly seen in aged peoples. The treatment options for all leukemia types include chemotherapy, biological therapy, radiation therapy, and bone marrow transplant.
The production of cells in bone marrow consists of several steps. Cells get converted into many intermediate types before forming white, red cells and platelets.
The treatment of leukemia is focused towards achieving a complete remission with minimal side-effects. Complete remission refers to absence of leukemia traces at cellular level. Patients who present no evidence of malignant cellular activity after completing the treatment of leukemia are considered to be completely cured. By contrast, relapse indicates a recurrence of leukemia specific symptoms and physiological signs.
In the case of patients with acute leukemia, a remission that lasts for more than five years after the treatment suggests a complete recovery. This five-year period is considered to be critical for leukemia sufferers, as it can make the difference between relapse and complete recovery.
In the last few decades, the five-year survival period of patients with leukemia has tripled. While in the 60's the five-year survival rate was around 15 percent, nowadays it revolves around 50 percent. This five-year survival period is strongly influenced by patients' age and the type of leukemia. Statistics indicate that the five-year survival rate for patients with acute lymphocytic leukemia (ALL) is around 60 percent, while the five-year survival rate for patients with chronic lymphocytic leukemia (CLL) is higher, reaching the value of 70 percent. By contrast, the prognosis of patients with myelogenous leukemia is less favorable. The same five-year survival rate for patients diagnosed with acute myelogenous leukemia (AML) is around 14 percent, while an estimated 32 percent of patients with chronic myelogenous leukemia (CML) exceed this five-year survival period.
Acute refers to the fact that this cancer has potential to become fatal in quick time. Acute lymphocytic leukemia requires immediate treatment otherwise recovery becomes impossible. It is mostly seen in childhood. Acute myelogenous and chronic cancer does not require immediate treatment.
Patient suffering from chronic leukemia are kept under observation and treated only when leukemia starts to damage body tissues. Chronic type is mostly seen in aged peoples. The treatment options for all leukemia types include chemotherapy, biological therapy, radiation therapy, and bone marrow transplant.
About the Author:
Sigita Kim What Do You Need to Know About a DUI Lawyer's Experience? How Can Mesothelioma Attorney Help You?